Cathay Accounts Payable vs Cash Analysis

688065 Stock   49.79  1.11  2.28%   
Cathay Biotech financial indicator trend analysis is way more than just evaluating Cathay Biotech prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cathay Biotech is a good investment. Please check the relationship between Cathay Biotech Accounts Payable and its Cash accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cathay Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Accounts Payable vs Cash

Accounts Payable vs Cash Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cathay Biotech Accounts Payable account and Cash. At this time, the significance of the direction appears to have weak relationship.
The correlation between Cathay Biotech's Accounts Payable and Cash is 0.32. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Cash in the same time period over historical financial statements of Cathay Biotech, assuming nothing else is changed. The correlation between historical values of Cathay Biotech's Accounts Payable and Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Cathay Biotech are associated (or correlated) with its Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash has no effect on the direction of Accounts Payable i.e., Cathay Biotech's Accounts Payable and Cash go up and down completely randomly.

Correlation Coefficient

0.32
Relationship DirectionPositive 
Relationship StrengthVery Weak

Accounts Payable

An accounting item on the balance sheet that represents Cathay Biotech obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Cathay Biotech are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Cash

Cash refers to the most liquid asset of Cathay Biotech, which is listed under current asset account on Cathay Biotech balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Cathay Biotech customers. The amounts must be unrestricted with restricted cash listed in a different Cathay Biotech account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.
Most indicators from Cathay Biotech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cathay Biotech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cathay Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
The current year's Tax Provision is expected to grow to about 56.8 M, whereas Selling General Administrative is forecasted to decline to about 83.2 M.
 2022 2023 2024 2025 (projected)
Interest Expense20.0M32.2M37.0M19.7M
Interest Income236.8M219.8M252.7M156.9M

Cathay Biotech fundamental ratios Correlations

-0.90.730.980.980.630.90.910.920.650.880.92-0.840.70.94-0.670.790.990.80.910.930.760.950.860.87
-0.9-0.47-0.96-0.81-0.33-0.97-0.66-0.91-0.9-0.84-0.820.65-0.57-0.730.72-0.54-0.92-0.65-0.98-0.71-0.95-0.82-0.58-0.58
0.73-0.470.660.80.960.50.820.540.060.540.8-0.770.490.78-0.360.980.710.920.510.820.290.70.860.86
0.98-0.960.660.940.540.940.840.910.750.850.93-0.750.620.86-0.650.710.990.790.950.870.840.890.780.79
0.98-0.810.80.940.720.820.970.870.520.840.92-0.840.720.96-0.610.850.970.820.820.970.640.930.940.94
0.63-0.330.960.540.720.320.80.47-0.070.50.7-0.680.570.74-0.360.960.60.810.340.80.110.580.850.85
0.9-0.970.50.940.820.320.660.880.860.820.82-0.740.50.75-0.670.550.920.671.00.690.960.870.570.58
0.91-0.660.820.840.970.80.660.790.330.790.84-0.820.770.96-0.560.880.880.760.660.990.440.870.990.99
0.92-0.910.540.910.870.470.880.790.790.990.79-0.810.850.89-0.90.660.90.560.880.840.80.910.710.71
0.65-0.90.060.750.52-0.070.860.330.790.720.55-0.40.450.45-0.710.160.690.280.860.410.950.60.210.22
0.88-0.840.540.850.840.50.820.790.990.720.76-0.830.910.9-0.940.670.850.50.810.840.740.910.70.71
0.92-0.820.80.930.920.70.820.840.790.550.76-0.730.560.84-0.560.820.940.880.850.880.70.830.820.82
-0.840.65-0.77-0.75-0.84-0.68-0.74-0.82-0.81-0.4-0.83-0.73-0.72-0.920.71-0.83-0.79-0.67-0.72-0.81-0.56-0.95-0.77-0.78
0.7-0.570.490.620.720.570.50.770.850.450.910.56-0.720.84-0.880.650.650.320.50.810.40.740.710.71
0.94-0.730.780.860.960.740.750.960.890.450.90.84-0.920.84-0.720.860.90.70.740.970.550.960.920.93
-0.670.72-0.36-0.65-0.61-0.36-0.67-0.56-0.9-0.71-0.94-0.560.71-0.88-0.72-0.51-0.65-0.28-0.67-0.63-0.67-0.74-0.46-0.47
0.79-0.540.980.710.850.960.550.880.660.160.670.82-0.830.650.86-0.510.760.870.560.880.350.770.90.9
0.99-0.920.710.990.970.60.920.880.90.690.850.94-0.790.650.9-0.650.760.810.930.910.790.910.840.84
0.8-0.650.920.790.820.810.670.760.560.280.50.88-0.670.320.7-0.280.870.810.690.770.520.680.790.79
0.91-0.980.510.950.820.341.00.660.880.860.810.85-0.720.50.74-0.670.560.930.690.70.960.860.580.59
0.93-0.710.820.870.970.80.690.990.840.410.840.88-0.810.810.97-0.630.880.910.770.70.50.870.970.97
0.76-0.950.290.840.640.110.960.440.80.950.740.7-0.560.40.55-0.670.350.790.520.960.50.720.340.35
0.95-0.820.70.890.930.580.870.870.910.60.910.83-0.950.740.96-0.740.770.910.680.860.870.720.810.81
0.86-0.580.860.780.940.850.570.990.710.210.70.82-0.770.710.92-0.460.90.840.790.580.970.340.811.0
0.87-0.580.860.790.940.850.580.990.710.220.710.82-0.780.710.93-0.470.90.840.790.590.970.350.811.0
Click cells to compare fundamentals

Cathay Biotech Account Relationship Matchups

Cathay Biotech fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets12.1B16.2B17.8B18.8B21.7B15.6B
Other Current Liab2.2M1.7M2.2M5.9M5.3M4.3M
Total Current Liabilities434.8M1.2B1.4B3.4B3.9B4.1B
Total Stockholder Equity10.4B10.7B10.9B11.2B12.8B10.5B
Retained Earnings1.2B1.4B1.8B2.1B2.4B1.6B
Accounts Payable353.2M302.3M1.1B1.7B1.9B2.0B
Cash5.7B9.6B6.3B5.4B6.2B6.0B
Non Current Assets Total3.7B4.8B9.4B11.3B13.0B7.1B
Non Currrent Assets Other572.3M938.5M1.8B876.5M1.0B918.8M
Net Receivables188.1M259.3M390.4M243.3M279.7M271.7M
Non Current Liabilities Total216.0M293.0M1.4B650.5M748.1M621.3M
Inventory775.1M1.2B1.6B1.5B1.7B1.3B
Other Current Assets296.8M231.9M80.9M287.2M258.5M193.1M
Total Liab650.7M1.5B2.8B4.1B4.7B4.9B
Net Invested Capital10.4B11.4B12.1B12.9B14.9B11.4B
Total Current Assets8.4B11.4B8.5B7.6B8.7B8.5B
Net Working Capital8.0B10.2B7.1B4.2B4.8B6.8B
Intangible Assets228.4M768.5M777.9M703.9M809.4M596.1M

Currently Active Assets on Macroaxis

Other Information on Investing in Cathay Stock

Balance Sheet is a snapshot of the financial position of Cathay Biotech at a specified time, usually calculated after every quarter, six months, or one year. Cathay Biotech Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Cathay Biotech and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Cathay currently owns. An asset can also be divided into two categories, current and non-current.